The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 13, 2022
Filed:
Jan. 17, 2014
Applicants:
Abivax, Paris, FR;
Centre National DE LA Recherche Scientifique, Paris, FR;
Universite DE Montpellier, Montpellier, FR;
Institut Curie, Paris, FR;
Inventors:
Jamal Tazi, Clapiers, FR;
Didier Scherrer, Castelnau le Lez, FR;
Aude Garcel, Le Cres, FR;
Noëlie Campos, Le Cres, FR;
Romain Najman, L'hay les Roses, FR;
Florence Mahuteau-Betzer, Saint Remy les Chevreuse, FR;
Assignees:
ABIVAX, Paris, FR;
CENTRE NATIONAL DE LA RECHERCHE, Paris, FR;
UNIVERSITE DE MONTPELLIER, Montpellier, FR;
INSTITUT CURIE, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12Q 1/6876 (2018.01); C12Q 1/70 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6876 (2013.01); C12Q 1/70 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01);
Abstract
A use of at least one miRNA, said at least one miRNA being miR-124, as a biomarker, in particular of a viral infection, or of an efficacy of a therapeutic treatment of said viral infection.